Financials National International Holding Company K.S.C.P.
Equities
NIH
KW0EQ0201677
Investment Holding Companies
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.105 KWD | 0.00% |
|
-1.87% | -2.78% |
06-06 | NIH Unaware of Reason for Unusual Trading Activity; Dubai Shares Flat, Kuwaiti Up | MT |
05-14 | National International Resumes Trading on Dubai Financial Market | MT |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 12.42 | 15.42 | 17.41 | 32.02 | 28.58 | 24.13 |
Enterprise Value (EV) 1 | 8.442 | 17.69 | 19.63 | 31 | 27.95 | 19.66 |
P/E ratio | 5.39 x | 8.82 x | -4.68 x | 17.4 x | 16.6 x | 10.6 x |
Yield | 8.02% | - | - | 3.32% | 3.85% | 5.56% |
Capitalization / Revenue | 1.52 x | 1.89 x | 111 x | 5.47 x | 4.18 x | 3.04 x |
EV / Revenue | 1.03 x | 2.16 x | 125 x | 5.3 x | 4.09 x | 2.47 x |
EV / EBITDA | 2.99 x | 5.56 x | -6.27 x | 14.5 x | 13.6 x | 6.79 x |
EV / FCF | 2.98 x | 8.06 x | -5.06 x | 19.3 x | 16.9 x | 4.38 x |
FCF Yield | 33.5% | 12.4% | -19.8% | 5.19% | 5.92% | 22.8% |
Price to Book | 0.31 x | 0.39 x | 0.47 x | 0.84 x | 0.77 x | 0.62 x |
Nbr of stocks (in thousands) | 216,611 | 216,611 | 216,611 | 216,950 | 219,827 | 223,445 |
Reference price 2 | 0.0573 | 0.0712 | 0.0804 | 0.1476 | 0.1300 | 0.1080 |
Announcement Date | 31/03/19 | 31/03/20 | 30/03/21 | 30/03/22 | 30/03/23 | 21/03/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 8.181 | 8.173 | 0.1572 | 5.85 | 6.84 | 7.951 |
EBITDA 1 | 2.821 | 3.183 | -3.131 | 2.131 | 2.05 | 2.895 |
EBIT 1 | 2.702 | 3.012 | -3.361 | 1.995 | 1.869 | 2.803 |
Operating Margin | 33.03% | 36.85% | -2,137.57% | 34.1% | 27.33% | 35.25% |
Earnings before Tax (EBT) 1 | 2.494 | 2.119 | -3.707 | 1.8 | 1.695 | 2.56 |
Net income 1 | 2.304 | 1.748 | -3.722 | 1.794 | 1.722 | 2.279 |
Net margin | 28.17% | 21.39% | -2,367.45% | 30.66% | 25.17% | 28.66% |
EPS 2 | 0.0106 | 0.008071 | -0.0172 | 0.008482 | 0.007824 | 0.0102 |
Free Cash Flow 1 | 2.83 | 2.194 | -3.882 | 1.608 | 1.655 | 4.492 |
FCF margin | 34.6% | 26.85% | -2,468.88% | 27.49% | 24.19% | 56.49% |
FCF Conversion (EBITDA) | 100.33% | 68.94% | - | 75.46% | 80.73% | 155.17% |
FCF Conversion (Net income) | 122.82% | 125.52% | - | 89.64% | 96.13% | 197.12% |
Dividend per Share 2 | 0.004600 | - | - | 0.004900 | 0.005000 | 0.006000 |
Announcement Date | 31/03/19 | 31/03/20 | 30/03/21 | 30/03/22 | 30/03/23 | 21/03/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 2.27 | 2.21 | - | - | - |
Net Cash position 1 | 3.97 | - | - | 1.02 | 0.63 | 4.47 |
Leverage (Debt/EBITDA) | - | 0.7124 x | -0.7065 x | - | - | - |
Free Cash Flow 1 | 2.83 | 2.19 | -3.88 | 1.61 | 1.65 | 4.49 |
ROE (net income / shareholders' equity) | 5.9% | 4.64% | -8.4% | 4% | 3.65% | 5.49% |
ROA (Net income/ Total Assets) | 3.5% | 3.58% | -4.14% | 2.39% | 2.12% | 3.19% |
Assets 1 | 65.76 | 48.83 | 89.85 | 75.2 | 81.23 | 71.42 |
Book Value Per Share 2 | 0.1900 | 0.1800 | 0.1700 | 0.1800 | 0.1700 | 0.1700 |
Cash Flow per Share 2 | 0.0300 | 0 | 0 | 0.0100 | 0.0100 | 0 |
Capex 1 | 0.23 | 0.27 | 0.43 | 0.36 | 0.08 | 0.09 |
Capex / Sales | 2.76% | 3.26% | 276.14% | 6.12% | 1.18% | 1.11% |
Announcement Date | 31/03/19 | 31/03/20 | 30/03/21 | 30/03/22 | 30/03/23 | 21/03/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-2.78% | 76.78M | |
+24.28% | 83.58B | |
+59.94% | 17.55B | |
+9.11% | 17.26B | |
+9.64% | 14.64B | |
-4.41% | 12.26B | |
+11.19% | 11.39B | |
-0.70% | 10.94B | |
+33.84% | 10.57B | |
+90.11% | 9.77B |
- Stock Market
- Equities
- NIH Stock
- Financials National International Holding Company K.S.C.P.